ATE203745T1 - Neue n-(arylsulfonyl)aminosäurederivate mit einer affinität für bradykininrezeptoren - Google Patents
Neue n-(arylsulfonyl)aminosäurederivate mit einer affinität für bradykininrezeptorenInfo
- Publication number
- ATE203745T1 ATE203745T1 AT97900243T AT97900243T ATE203745T1 AT E203745 T1 ATE203745 T1 AT E203745T1 AT 97900243 T AT97900243 T AT 97900243T AT 97900243 T AT97900243 T AT 97900243T AT E203745 T1 ATE203745 T1 AT E203745T1
- Authority
- AT
- Austria
- Prior art keywords
- arylsulfonyl
- affinity
- new
- amino acid
- acid derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/22—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/26—Radicals substituted by carbon atoms having three bonds to hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9600269A FR2743562B1 (fr) | 1996-01-11 | 1996-01-11 | Derives de n-(arylsulfonyl) aminoacides, leur preparation, les compositions pharmaceutiques en contenant |
PCT/FR1997/000026 WO1997025315A1 (fr) | 1996-01-11 | 1997-01-07 | Nouveaux derives de n-(arylsulfonyl)aminoacides ayant une affinite pour les recepteurs de la bradykinine |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE203745T1 true ATE203745T1 (de) | 2001-08-15 |
Family
ID=9488041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97900243T ATE203745T1 (de) | 1996-01-11 | 1997-01-07 | Neue n-(arylsulfonyl)aminosäurederivate mit einer affinität für bradykininrezeptoren |
Country Status (12)
Country | Link |
---|---|
US (3) | US6015812A (de) |
EP (1) | EP0877737B1 (de) |
JP (1) | JP4086316B2 (de) |
AT (1) | ATE203745T1 (de) |
AU (1) | AU1383297A (de) |
BR (1) | BR9707120B1 (de) |
DE (1) | DE69705930T2 (de) |
ES (1) | ES2162231T3 (de) |
FR (1) | FR2743562B1 (de) |
MX (1) | MX9805289A (de) |
NO (1) | NO310975B1 (de) |
WO (1) | WO1997025315A1 (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5837815A (en) * | 1994-12-15 | 1998-11-17 | Sugen, Inc. | PYK2 related polypeptide products |
DE69716449T2 (de) * | 1996-08-28 | 2003-08-07 | Procter & Gamble | Substituierte zyklische amine als metalloproteaseinhibitoren |
GB9621814D0 (en) * | 1996-10-19 | 1996-12-11 | British Biotech Pharm | Metalloproteinase inhibitors |
FR2765222B1 (fr) * | 1997-06-27 | 1999-12-31 | Fournier Ind & Sante | Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique |
NZ503945A (en) | 1997-07-31 | 2002-11-26 | Procter & Gamble | Metalloprotease-inhibiting amide derivatives |
US6861442B1 (en) * | 1998-12-30 | 2005-03-01 | Sugen, Inc. | PYK2 and inflammation |
CN1349498A (zh) | 1999-03-03 | 2002-05-15 | 宝洁公司 | 含有链烯基和炔基的金属蛋白酶抑制剂 |
MXPA01008857A (es) | 1999-03-03 | 2002-07-02 | Procter & Gamble | Inhibidores de metaloproteasa dihetero sustituidos. |
GB9913079D0 (en) * | 1999-06-04 | 1999-08-04 | Novartis Ag | Organic compounds |
FR2819254B1 (fr) * | 2001-01-08 | 2003-04-18 | Fournier Lab Sa | Nouveaux composes de la n-(phenylsulfonyl) glycine, leur procede de preparation et leur utilisation pour obtenir des compostions pharmaceutiques |
FR2822827B1 (fr) * | 2001-03-28 | 2003-05-16 | Sanofi Synthelabo | Nouveaux derives de n-(arylsulfonyl) beta-aminoacides comportant un groupe aminomethyle substitue, leur procede de preparation et les compositions pharmaceutiques en contenant |
ES2340664T3 (es) * | 2001-05-14 | 2010-06-08 | Novartis Ag | Derivados de sulfonamidas. |
US6919343B2 (en) * | 2002-02-08 | 2005-07-19 | Merck & Co., Inc. | N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives |
CA2473778A1 (en) * | 2002-02-08 | 2003-08-14 | Merck & Co., Inc. | N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
JP2005531506A (ja) | 2002-03-01 | 2005-10-20 | メルク エンド カムパニー インコーポレーテッド | Edg受容体作動薬としてのアミノアルキルホスホネートおよび関連化合物 |
FR2840897B1 (fr) * | 2002-06-14 | 2004-09-10 | Fournier Lab Sa | Nouveaux derives d'arylsulfonamides et leur utilisation en therapeutique |
ES2278213T3 (es) * | 2002-11-07 | 2007-08-01 | MERCK & CO., INC. | Derivados de fenilamina como inhibidores de la dipeptidilpeptidasa en el tratamiento o la prevencion de la diabetes. |
FR2852958B1 (fr) * | 2003-03-25 | 2005-06-24 | Fournier Lab Sa | Nouveaux derives de benzenesulfonamides et leur utilisation en therapeutique |
DE602004021358D1 (de) * | 2003-03-25 | 2009-07-16 | Fournier Lab Sa | Benzosulfonamide derivate, deren verfahren zum herstellung, und deren verwendung zur behandlung von schmerzen |
US7211566B2 (en) * | 2003-04-01 | 2007-05-01 | Universite De Sherbrooke | Selective bradykinin (BK) B1 peptidic receptor antagonists and uses thereof |
US7425631B2 (en) | 2003-04-10 | 2008-09-16 | Amgen Inc. | Compounds and methods of use |
MXPA05010883A (es) | 2003-04-10 | 2006-01-23 | Amgen Inc | Derivados de amina ciclica y su uso en el tratamiento de trastornos inflamatorios relacionados mediados por bradiquinina. |
CA2583267A1 (en) * | 2004-10-12 | 2006-04-27 | Amgen Inc. | Novel b1 bradykinin receptor antagonists |
US7612060B2 (en) | 2004-10-13 | 2009-11-03 | Amgen Inc. | Triazoles and methods of use |
JP2011512329A (ja) * | 2008-02-06 | 2011-04-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 有効な鎮痛剤としてのアリールスルホンアミド |
MX2010011095A (es) * | 2008-04-08 | 2010-11-05 | Gruenenthal Gmbh | Derivados de sulfonamidas sustituidos. |
EP2396301A2 (de) | 2009-02-13 | 2011-12-21 | Jerini AG | Niedermolekulare antagonisten des bradykinin-b1-rezeptors |
WO2011000863A1 (en) * | 2009-07-01 | 2011-01-06 | Dsm Ip Assets B.V. | Sulfonamide derivatives for use in the treatment of skin conditions |
EP2316820A1 (de) | 2009-10-28 | 2011-05-04 | Dompe S.p.A. | Als Bradykinin-Rezeptorantagonisten nützliche 2-Arylpropionamid-Derivate und pharmazeutische Zusammensetzungen damit |
PT2813502T (pt) * | 2013-06-14 | 2017-04-06 | Dompé Farm S P A | Antagonistas do recetor da bradicinina e composições farmacêuticas que os contêm |
WO2019142191A1 (en) * | 2018-01-17 | 2019-07-25 | Gavish-Galilee Bio Applications Ltd. | New methionine metabolic pathway inhibitors |
CN111699182A (zh) | 2018-01-17 | 2020-09-22 | 米加尔-加利里研究院有限公司 | 新型蛋氨酸代谢途径抑制剂 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2701480B1 (fr) * | 1993-02-15 | 1995-05-24 | Sanofi Elf | Composés à groupe sulfamoyle et amidino, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
-
1996
- 1996-01-11 FR FR9600269A patent/FR2743562B1/fr not_active Expired - Fee Related
-
1997
- 1997-01-07 US US09/101,214 patent/US6015812A/en not_active Expired - Lifetime
- 1997-01-07 JP JP52491697A patent/JP4086316B2/ja not_active Expired - Fee Related
- 1997-01-07 AT AT97900243T patent/ATE203745T1/de not_active IP Right Cessation
- 1997-01-07 BR BRPI9707120-0A patent/BR9707120B1/pt not_active IP Right Cessation
- 1997-01-07 EP EP97900243A patent/EP0877737B1/de not_active Expired - Lifetime
- 1997-01-07 WO PCT/FR1997/000026 patent/WO1997025315A1/fr active IP Right Grant
- 1997-01-07 ES ES97900243T patent/ES2162231T3/es not_active Expired - Lifetime
- 1997-01-07 DE DE69705930T patent/DE69705930T2/de not_active Expired - Lifetime
- 1997-01-07 AU AU13832/97A patent/AU1383297A/en not_active Abandoned
-
1998
- 1998-06-29 MX MX9805289A patent/MX9805289A/es not_active IP Right Cessation
- 1998-07-10 NO NO19983190A patent/NO310975B1/no not_active IP Right Cessation
-
1999
- 1999-11-04 US US09/434,333 patent/US6100278A/en not_active Expired - Lifetime
-
2000
- 2000-06-13 US US09/593,067 patent/US6313120B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
MX9805289A (es) | 1998-10-31 |
BR9707120B1 (pt) | 2010-10-05 |
DE69705930D1 (de) | 2001-09-06 |
FR2743562B1 (fr) | 1998-04-03 |
US6313120B1 (en) | 2001-11-06 |
AU1383297A (en) | 1997-08-01 |
ES2162231T3 (es) | 2001-12-16 |
US6015812A (en) | 2000-01-18 |
BR9707120A (pt) | 1999-07-20 |
FR2743562A1 (fr) | 1997-07-18 |
US6100278A (en) | 2000-08-08 |
JP4086316B2 (ja) | 2008-05-14 |
DE69705930T2 (de) | 2002-04-11 |
WO1997025315A1 (fr) | 1997-07-17 |
EP0877737B1 (de) | 2001-08-01 |
JP2000504315A (ja) | 2000-04-11 |
NO310975B1 (no) | 2001-09-24 |
EP0877737A1 (de) | 1998-11-18 |
NO983190L (no) | 1998-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE203745T1 (de) | Neue n-(arylsulfonyl)aminosäurederivate mit einer affinität für bradykininrezeptoren | |
TR200101398T2 (tr) | Pirolidin türevleri-CCR-3 reseptörü antagonistleri. | |
DE69429984D1 (de) | In position 3 durch eine stickstoffgruppe substituierte 1,3-dihydroindol-2-on derivate als vasopressin und/oder ocytocin agonisten und/oder antagonisten | |
ATE219064T1 (de) | Piperazinderivative als tachykinin antagonisten | |
TR199801594A2 (xx) | CCR-3 resept�r antagonistleri. | |
ATE286038T1 (de) | Verbindungen mit sulfonsäure-amidgruppe | |
DE60103050D1 (de) | Spiro[2.4]heptanaminocarbonsäure und ihre derivate | |
PT896533E (pt) | Pentafluorobenzenosulfonamidas e analogos | |
MXPA02001340A (es) | Compuestos novedosos 1,4-benzodiazepina y derivados de los mismos. | |
ATE230392T1 (de) | Amidinophenyl-pyrrolidine, -pyrroline und - isoxazolidine und ihre derivate | |
PT1007523E (pt) | Derivados indole e 2,3-di-ridroindole, sua preparacao e utilizacao | |
TR200002542T2 (tr) | Meta-azasiklik amino benzoik asit bileşikleri ve bunların integrin antagonistleri olan türevleri | |
SE9703414D0 (sv) | New compounds | |
ATE275545T1 (de) | Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d | |
EA200201138A1 (ru) | Пептид, модулирующий рецептор тромбопоэтина | |
ATE199013T1 (de) | N-(4-substituerte benzyl)-2-aminolactamderivate | |
YU44301A (sh) | 5ht1 antagonisti za antidepresantnu terapiju | |
DE59510713D1 (de) | N-substituierte 3-azabicyclo(3.2.0)heptan-derivate als neuroleptika | |
ATE165101T1 (de) | Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika | |
ATE254122T1 (de) | Indolderivate als 5-ht1b und 5-ht1d agonisten | |
TR199901380A2 (xx) | Di-ya da triazo-spiro$4,5] dekan t�revleri | |
ATE441642T1 (de) | Hydantoin derivate mit affinität für somatostatin rezeptoren | |
DE69939586D1 (de) | Inhibitoren für die gefässneubildung | |
MX9603199A (es) | Antagonistas de receptores a endotelina. | |
PT1115404E (pt) | Utilizacao de antagonistas prostanoides para o tratamento de cefaleias primarias |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |